Aru Narendran
Affiliations: | University of Calgary, Calgary, Alberta, Canada |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Aru Narendran"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sarkar S, Chanda A, Khanolkar RA, et al. (2024) Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy. Biomedicines. 12 |
Sharma R, Zhang C, Narendran A. (2023) The Small-Molecule E26-Transformation-Specific Inhibitor TK216 Attenuates the Oncogenic Properties of Pediatric Leukemia. Genes. 14 |
Sharma R, Incoronato A, Zhang C, et al. (2023) Establishment of a t(11;19), KMT2A Rearranged B-ALL Cell Line for Preclinical Evaluation and Novel Therapeutics Development for Refractory Infant Leukemia. Journal of Pediatric Hematology/Oncology. 45: e750-e756 |
Grundy M, Narendran A. (2022) The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents. Frontiers in Pediatrics. 10: 910268 |
Banderali U, Jain M, Thakur S, et al. (2021) The T-type Calcium Channel Cav3.1 in Y79 Retinoblastoma Cells is Regulated by the Epidermal Growth Factor Receptor via the MAPK Signaling Pathway. Current Eye Research. 1-10 |
Al-Ghabkari A, Narendran A. (2021) Targeting EZH2-mediated methylation of histone 3 inhibits proliferation of pediatric acute monocytic leukemia cells . Cancer Biology & Therapy. 22: 333-344 |
Thakur S, Ruan Y, Jayanthan A, et al. (2021) Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib. Current Cancer Drug Targets |
Thakur S, Ruan Y, Zhang C, et al. (2020) Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells. Cancer Gene Therapy |
Obaid H, Kannappan S, Gupta M, et al. (2019) In Vitro Investigation Demonstrates IGFR/VEGFR Receptor Cross Talk and Potential of Combined Inhibition in Pediatric Central Nervous System Atypical Teratoid Rhabdoid Tumors. Current Cancer Drug Targets |
Brennan L, Narendran A. (2019) Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia. Stem Cells and Development |